Evidence map›Paper›PMID 35722349›Full record

ArticleFrontiers in microbiology2022

A Novel Breakthrough in

Luis G V Fernandes, Ana L T O Nascimento

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Transposon Sequencing in Leptospira interrogans.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Bioinformatic Identification of CRISPR-Cas Systems inPathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. LipL41 and LigA/LigB Gene Silencing on a LipL32 KnockoutPathogens (Basel, Switzerland) · 2023
    Article
  10. The Arsenal ofAntioxidants (Basel, Switzerland) · 2023
    Review
  11. Evaluation ofFrontiers in microbiology · 2023
    Article
  12. Transcriptional analysis of CRISPR I-B arrays ofFrontiers in microbiology · 2022
    Article
  13. Frontiers in molecular biosciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Luis G V FernandesLaboratorio de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo, Brazil.
Ana L T O NascimentoLaboratorio de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo, Brazil.
Instituto Butantan · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptospirosis is of general concern as it is a widespread zoonotic disease caused by pathogenic species of the genus

Indexed as

CRISPR/Cas9knockout mutantsLeptospira biflexaLeptospira interrogansleptospirosisMycobacterium smegmatisMycobacterium tuberculosisnon-homologous end-joining

Identifiers

PMID35722349
PMCPMC9199861
OpenAlexW4283386345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.